These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15823917)

  • 1. A single local injection of recombinant VEGF receptor 2 but not of Tie2 inhibits retinal neovascularization in the mouse.
    Agostini H; Boden K; Unsöld A; Martin G; Hansen L; Fiedler U; Esser N; Marmé D
    Curr Eye Res; 2005 Apr; 30(4):249-57. PubMed ID: 15823917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory Effects On Retinal Neovascularization by Ranibizumab and sTie2-Fc in An Oxygen-Induced Retinopathy Mouse Model.
    Jiang C; Ruan L; Zhang J; Huang X
    Curr Eye Res; 2018 Sep; 43(9):1190-1198. PubMed ID: 29857790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
    Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF, Ang-2 and SRIF associated abnormal postnatal development of the retinal capillary network in the Royal College of Surgeons rat.
    Prokosch V; Fink J; Heiduschka P; Melkonyan H; Thanos S
    Exp Eye Res; 2011 Feb; 92(2):128-37. PubMed ID: 21147101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.
    Unsoeld AS; Junker B; Mazitschek R; Martin G; Hansen LL; Giannis A; Agostini HT
    Mol Vis; 2004 Jul; 10():468-75. PubMed ID: 15273654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
    Kociok N; Krohne TU; Poulaki V; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy.
    Chen J; Joyal JS; Hatton CJ; Juan AM; Pei DT; Hurst CG; Xu D; Stahl A; Hellstrom A; Smith LE
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2968-77. PubMed ID: 22491401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice.
    Kociok N; Radetzky S; Krohne TU; Gavranic C; Joussen AM
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5057-65. PubMed ID: 17065527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril and vascular endothelial growth factor in a mouse model of retinopathy.
    Higgins RD; Yan Y; Geng Y; Sharma J; Barr SM
    Curr Eye Res; 2003 Aug; 27(2):123-9. PubMed ID: 14632165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
    Dal Monte M; Ristori C; Cammalleri M; Bagnoli P
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3596-606. PubMed ID: 19324858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
    Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
    Nagai N; Noda K; Urano T; Kubota Y; Shinoda H; Koto T; Shinoda K; Inoue M; Shiomi T; Ikeda E; Tsubota K; Suda T; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1078-84. PubMed ID: 15728568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
    Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of retinal neovascularization by small-interference RNA targeting erythropoietin.
    Xiong SQ; Xia XB; Xu HZ; Jiang J
    Ophthalmologica; 2009; 223(5):306-12. PubMed ID: 19407475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice.
    Maier P; Unsoeld AS; Junker B; Martin G; Drevs J; Hansen LL; Agostini HT
    Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):593-600. PubMed ID: 15650859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
    Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
    Ehlken C; Martin G; Lange C; Gogaki EG; Fiedler U; Schaffner F; Hansen LL; Augustin HG; Agostini HT
    Acta Ophthalmol; 2011 Feb; 89(1):82-90. PubMed ID: 19764912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.
    Fang X; Ueno M; Yamashita T; Ikuno Y
    Curr Eye Res; 2011 Nov; 36(11):1028-36. PubMed ID: 21999228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.